AspenBio Pharma Inc.
Description Venaxis, Inc. develops and commercializes products for unmet diagnostic and therapeutic needs. The companys research and development activities primarily focus on a human acute appendicitis blood-based test. Its lead product candidate includes APPY1, a blood-based diagnostic test designed to aid in the evaluation of patients for acute appendicitis. The company, through its license agreement with Washington University in St. Louis, develops, markets, distributes, imports, and exports luteinizing hormone and/or follicle-stimulating hormone products for cattle, equine, and swine animals. The company was formerly known as AspenBio Pharma, Inc. and changed its name to Venaxis, Inc. in December 2012. Venaxis, Inc. was founded in 2000 and is based in Castle Rock, Colorado. To view the detailed information, you need to SUBSCRIBE with us. |
 |